Skip to main content
. Author manuscript; available in PMC: 2018 Jul 11.
Published in final edited form as: Pharmacogenomics. 2014 Apr;15(6):759–774. doi: 10.2217/pgs.14.39

Table 5.

Late stage gene-expression (stage III, 24–48 h) responses.

GO ID Cellular component Bonferroni p-value
44421 Extracellular region part 9.70 × 10−14
5576 Extracellular region 1.16 × 10−13
5615 Extracellular space 7.63 × 10−12
31012 Extracellular matrix 3.46 × 10−9
9986 Cell surface 8.26 × 10−6
44459 Plasma membrane part 2.09 × 10−5
5740 Mitochondrial envelope 7.07 × 10−5
5739 Mitochondrion 8.01 × 10−5
5578 Proteinaceous extracellular matrix 1.70 × 10−4
267 Cell fraction 4.79 × 10−4
44429 Mitochondrial part 9.15 × 10−4
31966 Mitochondrial membrane 9.90 × 10−4

Cellular component terms significantly modified following rosiglitazone treatment are presented. Bonferroni-adjusted p-values are provided.